AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2018
Feb 20, 2018
29821_dirs_2018-02-20_055fca79-c1e7-4652-baee-4f68fc61472e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-02-15
Reporting Person: Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-15 | Deferred Stock Units | $ | A | 23071.0000 | Acquired | 2023-02-15 | Common Stock (23071.0000) | Direct |
| 2018-02-15 | Stock Option (Right to Buy) | $27.0900 | A | 69521.0000 | Acquired | 2028-02-15 | Common Stock (69521.0000) | Direct |
Footnotes
F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.